# BioAge Labs Inc. (BIOA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $9.59, market value $440 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). BioAge Labs Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 42.5×**. Each dollar of revenue is priced at 42.5×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 1.2×**. The shares trade at 1.2× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -20.0%** (5-yr avg -50.4%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Net margin: -896.1%**. The company reported a net loss over the last twelve months.
- **Return on equity: -29.6%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -97.8%**. Return on all capital, debt included, is -97.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -32.0%**. Each dollar of assets produces -32.0% of profit.

## Growth
- **EPS growth (1 yr): 66.2%**. Earnings per share rose 66.2%.

## Financial health
- **Debt to equity: 0.01**. Debt is 0.01 times equity: a conservative balance sheet.
- **Altman Z-score: 11.85**. A Z-score of 11.85 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. BioAge Labs Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 103.6%** (YTD -27.5%, 3-mo -38.9%). The shares are up 103.6% over twelve months including dividends.
- **From 52-week high: -63.1%** (104.9% above the low). Trading 63% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 34**. An RSI of 34 is neutral.
- **Beta (1 yr): 1.75** (volatility 109%). Beta of 1.75 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BIOA · Page: https://foliofundamentals.com/stocks/bioa

Not investment advice.